News Release Detail

July 24, 2002

Mylan Names Gary E. Sphar Vice President-Corporate Controller

Mylan Names Gary E. Sphar Vice President-Corporate ControllerPITTSBURGH, Jul 24, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE: MYL) announced today that Gary E. Sphar was named Vice President-Corporate Controller. Mr. Sphar will be responsible for accounting policies and functions, internal and external financial reporting, budgeting, forecasting and financial systems.

Mr. Sphar joined Mylan in February of 1992 as Manager of Corporate Accounting. Since that time Mr. Sphar has served in various senior capacities and as of January 2001, Vice President of Finance for Mylan Pharmaceuticals Inc. Additionally, Mr. Sphar assumed the responsibilities of Chief Financial Officer from June 2001 until March 2002. Mr. Sphar will continue to report to Ed Borkowski, CFO of Mylan Laboratories Inc.

"Gary's performance has clearly demonstrated his capabilities and commitment to Mylan," stated Milan Puskar, Chairman and CEO. "Gary's elevation to the position of Corporate Controller is a continuation of our ongoing commitment to further enhance the depth of our management team."

Mr. Sphar began his career with Deloitte & Touche LLP. He received his Bachelor of Science in Accounting from Point Park College.

Mylan Laboratories Inc., is a leading pharmaceutical company that develops, manufacturers and markets generic and proprietary prescription pharmaceutical products. The company markets an extensive line of generic products through three business units, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., and UDL Laboratories, Inc. and branded products through its Bertek Pharmaceuticals Inc. subsidiary. For more information, visit www.mylan.com

CONTACT:          Mylan Laboratories Inc., Pittsburgh, PA 
                  Patricia Sunseri, 412/232-0100

URL:              http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2002 Business Wire.  All rights reserved.
Email Alerts
Investor FAQs
Contact Us
LinkedIn